Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557

Watchlist Manager
Jiangsu Kanion Pharmaceutical Co Ltd Logo
Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557
Watchlist
Price: 14.31 CNY 1.71% Market Closed
Market Cap: 8.2B CNY
Have any thoughts about
Jiangsu Kanion Pharmaceutical Co Ltd?
Write Note

Jiangsu Kanion Pharmaceutical Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jiangsu Kanion Pharmaceutical Co Ltd
Revenue Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557
Revenue
ÂĄ4.6B
CAGR 3-Years
12%
CAGR 5-Years
2%
CAGR 10-Years
7%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Revenue
ÂĄ10.1B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Revenue
ÂĄ10.7B
CAGR 3-Years
14%
CAGR 5-Years
15%
CAGR 10-Years
22%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Revenue
ÂĄ25.3B
CAGR 3-Years
-5%
CAGR 5-Years
5%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Revenue
ÂĄ39.3B
CAGR 3-Years
3%
CAGR 5-Years
7%
CAGR 10-Years
9%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Revenue
ÂĄ561.9m
CAGR 3-Years
-18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Jiangsu Kanion Pharmaceutical Co Ltd's Revenue?
Revenue
4.6B CNY

Based on the financial report for Jun 30, 2024, Jiangsu Kanion Pharmaceutical Co Ltd's Revenue amounts to 4.6B CNY.

What is Jiangsu Kanion Pharmaceutical Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
7%

Over the last year, the Revenue growth was -5%. The average annual Revenue growth rates for Jiangsu Kanion Pharmaceutical Co Ltd have been 12% over the past three years , 2% over the past five years , and 7% over the past ten years .

Back to Top